/

MDCX

Medicus Pharma Ltd.Closed

3.58−1.03 −22.26%USD

NasdaqCM · as of Oct 12, 16:00 ET · 15m delayAfter hours 3.82 +6.70%

Open

4.20

Prev close

4.61

Day range

3.584.69

52-week range

3.58139.00

Volume

122.79K1.23×

Mkt cap

5.13M

P/E ttm

—

Fwd P/E

-0.15

EPS ttm

-150.38

Div yield

0.00%

Earnings

—

From 52w high

−97.42%

Price Chart

Yahoo Finance · delayed

MDCXOct 12, 2026O 4.20H 4.69L 3.58C 3.58−1.02 (−22.17%)Vol 123.20K

SMA 5010.72
SMA 20028.02

1Y change −97.11% since Oct 10, 2025 close477 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

MDCX Medicus Pharma Ltd. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −57.13%
1 month: −56.07%
3 months: −80.75%
6 months: −82.19%
Year to date: −95.32%
1 year: −97.11%

Valuation & ownership

Market cap: 5.13M
Enterprise value: 11.03M
P/E (ttm): —
Forward P/E: -0.15
PEG ratio: —
Price / book: —
Price / sales (ttm): —
EV / EBITDA: —
EPS (ttm): -150.38
EPS (forward): -24.00
Beta (5y monthly): -0.30
Dividend yield: 0.00%
Payout ratio: —
Shares outstanding: 1.43M
Float: 1.05M
Short % of float: 5.36%
Short ratio (days): 0.38
Held by insiders: 93.32%
Held by institutions: 2.83%
Avg volume (3m): 99.49K
50-day average: 10.72
200-day average: 28.02
52-week change: −97.11%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): oversold 18.4
vs 50-day SMA: −66.61%
vs 200-day SMA: −87.22%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 26.94%
Realised vol (20d, ann.): 188.2%
From 52-week high: −97.42%
From 52-week low: 0.00%

ANR

Analyst Consensus

4 analysts

Consensus

—

Mean target

225.00

+6,184.92% implied

Low 50.00Median 200.00High 450.00

Recommendation trend

Now4 / 0 / 0
1m ago4 / 0 / 0
2m ago

DES

About Medicus Pharma Ltd.

Yahoo Finance profile

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.

Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 16
Headquarters: West Conshohocken, PA, United States
Website: medicuspharma.com
Officers: Dr. Raza Bokhari M.B.A., M.D. CEO & Executive Chairman
Dr. Edward J. Brennan Jr., F.A.C.S., M.D. Chief Scientific Officer and Head of R&D Program
Dr. Faisal Mehmud M.D. Chief Medical Officer
Mr. Andrew Alasdair Smith Chief Operating Officer

SEAS

Seasonality · MDCX

2024–2026 · monthly returns

Strongest month Feb +53.46%Weakest month May −39.34%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-22.2	28.6	-70.0	-38.3	33.9	17.7	-38.3	-4.7	-38.5	-55.5			−95.3%
2025	7.0	53.5	-6.8	13.0	-39.3	17.3	-17.7	-21.1	19.3	5.4	-9.8	-30.5	−37.0%
2024												-9.9	−9.9%

INSD

Insider Activity · MDCX

Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Sep 3, 2026	Smith Andrew AlasdairChief Operating Officer	Stock Award(Grant) at price 0.17 per share.	735.3K	$125.37K
Sep 3, 2026	Bokhari RazaChief Executive Officer	Stock Award(Grant) at price 0.17 per share.	2.94M	$501.47K
Sep 3, 2026	Brennan Edward Joseph JrOfficer	Stock Award(Grant) at price 0.17 per share.	588.2K	$100.29K
Sep 3, 2026	Mehmud Faisal M.D.Officer	Stock Award(Grant) at price 0.17 per share.	1.47M	$250.74K
Sep 3, 2026	Bonner Carolyn FPresident	Stock Award(Grant) at price 0.17 per share.	1.47M	$250.74K
Aug 12, 2025	Quinlan James PChief Financial Officer	Conversion of Exercise of derivative security at price 0.81 - 2.75 per share.	145K	$156.25K
May 19, 2025	Velocity Fund Partners, LpBeneficial Owner of more than 10% of a Class of Security	Sale at price 7.72 per share.	75K	$578.94K

MDCX

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

MDCX

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Medicus Pharma Ltd.

Seasonality · MDCX

Insider Activity · MDCX

Congress Trades · MDCX

Congress Trades · MDCX

Insider Activity · MDCX

Seasonality · MDCX

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Medicus Pharma Ltd.

Financial Snapshot

Earnings & Dividends

News